QIN
Click for more information
0.00% 29.5¢ quintis ltd

Santalis FDA phase 2 details, page-5

  1. CjsfromNSW
    1,460 Posts.
    clock Created with Sketch.
    02/11/17
    13:28
    Post #: 28437813
    Yes I thought there was phase 3 trial going on from the annual report - but HT seems to, as usual, scoff at any positive notion regarding QIN, citing what appears to be evidence from 2014 - I could be wrong of course.

    Ah well mid 2018 is not too far away and perhaps the matter will be revealed in the upcoming info releases form the coy.
    QIN Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
watchlist Created with Sketch. Add QIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.